Lanean...
Cancer-targeted therapies and radiopharmaceuticals
The treatment of bone metastases remains a clinical challenge. Although a number of well-established agents, namely bisphosphonates and denosumab, are available to reduce the occurrence of skeletal-related events, additional cancer-targeted therapies are required to improve patients' prognosis...
Gorde:
| Argitaratua izan da: | Bonekey Rep |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4455688/ https://ncbi.nlm.nih.gov/pubmed/26131359 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2015.76 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|